Page last updated: 2024-10-24

cefuroxime and Skin Diseases, Infectious

cefuroxime has been researched along with Skin Diseases, Infectious in 6 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Skin Diseases, Infectious: Skin diseases caused by bacteria, fungi, parasites, or viruses.

Research Excerpts

ExcerptRelevanceReference
" Each drug was given at a dosage of 30 mg/kg of body weight per day in two divided doses."2.67Evaluation of cefuroxime axetil and cefadroxil suspensions for treatment of pediatric skin infections. ( Brown, WD; Chartrand, S; Darden, P; Drehobl, MA; Jacobs, RF; Ossi, MJ; Yetman, R, 1992)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bucko, AD1
Hunt, BJ1
Kidd, SL1
Hom, R1
Failla, S1
Longo, D1
Fichera, M1
Jacobs, RF1
Brown, WD1
Chartrand, S1
Darden, P1
Drehobl, MA1
Yetman, R1
Ossi, MJ1
Gentry, LO1
Gooch, WM1
Kaminester, L1
Cole, GW1
Binder, R1
Morman, MR1
Swinehart, JM1
Wisniewski, M1
Yilmaz, HM1
Collins, JJ1
Gudgeon, AC1
Vandenburg, MJ1
Wight, LJ1
Griffiths, GK1
Kelsey, M1

Reviews

1 review available for cefuroxime and Skin Diseases, Infectious

ArticleYear
Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14, Issue:1

    Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Age

1992

Trials

3 trials available for cefuroxime and Skin Diseases, Infectious

ArticleYear
Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.
    Clinical therapeutics, 2002, Volume: 24, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefadroxil; Cefuroxime; Cephalosp

2002
Evaluation of cefuroxime axetil and cefadroxil suspensions for treatment of pediatric skin infections.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:8

    Topics: Cefadroxil; Cefuroxime; Child; Child, Preschool; Female; Humans; Infant; Male; Prodrugs; Single-Blin

1992
Clinical comparison of cefuroxime axetil, cephalexin and cefadroxil in the treatment of patients with primary infections of the skin or skin structures.
    Dermatologica, 1991, Volume: 183, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefadroxil; Cefuroxime; Cephalexin; Cephalosporins; Chil

1991

Other Studies

2 other studies available for cefuroxime and Skin Diseases, Infectious

ArticleYear
[Use of cefuroxime in infective pluriorgan pathology. Observations on 60 cases].
    La Clinica terapeutica, 1984, Nov-15, Volume: 111, Issue:3

    Topics: Adolescent; Aged; Bacterial Infections; Biliary Tract Diseases; Cefuroxime; Cephalosporins; Female;

1984
Is oral cefuroxime axetil suitable for the treatment of unidentified bacterial infection of skin and soft tissue?
    The British journal of clinical practice, 1987, Volume: 41, Issue:10

    Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Cefuroxime; Cephalosporins; Consumer Behavi

1987